KORU Medical Systems Inc
Research KORU Medical Systems Inc (KRMD) on Bullrun: market cap USD 148.14M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKRMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 148.14M
- Financial periodQ2 2026
- RevenueUSD 12.05M
- Net incomeUSD 252.45K
- Free cash flow-USD 361.25K
- Gross margin65.1%
Valuation Snapshot
latest market cap is USD 148.14M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 41.13M | -USD 2.64M | -USD 470.11K | 62.3% | -0.06 | USD 8.87M | USD 3.50M | USD 17.05M |
| FY2024 | USD 33.65M | -USD 6.07M | -USD 1.62M | 63.4% | -0.13 | USD 9.58M | USD 3.99M | USD 16.81M |
| FY2023 | USD 28.52M | -USD 13.74M | -USD 5.68M | 58.6% | -0.3 | USD 11.48M | USD 4.45M | USD 20.35M |
| FY2022 | USD 27.90M | -USD 8.66M | -USD 8.17M | 55.1% | -0.19 | USD 17.41M | USD 4.54M | USD 31.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 148.14M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 269.41M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 176.93M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 111.89M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 161.65M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 133.87M | n/a | n/a | n/a |
About KORU Medical Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).
Related stock research
Other Healthcare stocks
Frequently asked questions
What is KORU Medical Systems Inc's market cap?
KORU Medical Systems Inc's market capitalization is USD 148.14M.
What does KORU Medical Systems Inc do?
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).